Biomed Conference will be held at InterContinental David Tel Aviv from 20-22 May 2025.
Biomed Israel, the largest and most important meeting place between Israeli health professionals and their colleagues and partners from around the world, will meet at the David InterContinental Hotel in Tel Aviv.
This event is a unique opportunity for global health care and health technology leaders to discover the innovative and dynamic life sciences and biomedicine industry in Israel and to participate in three days of intensive networking to discover business opportunities and promote partnerships.
As in previous years, more than 100 Israeli companies specializing in life sciences, whether they are promising start-ups or more established companies, will showcase and showcase their innovative products and technologies.
Co-chaired by Ruti Alon, founder and CEO of Medstrada, Ora Dar, PhD, Senior Expert in Medical Sciences and Health Innovation, and Nissim Darvish, MD, PhD, Managing General Partner, Eliraz Ventures, the conference will explore and focus on the innovations and trends that shape the future of health care systems and life sciences.
« In times of uncertainty, our determination to collaborate and seek to resolve unmet global health care needs is a glimmer of hope and becoming our greatest strength« , said Ruti Alon. « The primary objective of Biomed Israel is to stimulate collaboration between the innovative health technology ecosystem in Israel and the global life sciences industry. Senior executives of multinationals, large pharmaceutical companies, medical devices, technology giants and international health investors come to Israel every May to « buy » innovations in this area, seeking creative solutions, products and technologies and the next big innovation. ».
« The conference will highlight the best of what Israel has to offer in a variety of fields and indications that coincide with current trends in the global life sciences industry. The experts will participate in stimulating discussions and presentations on a wide range of topics, ranging from new models of biological diseases to large amounts of available data that need to be processed and analyzed to be transformed into knowledge. These themes will be complemented by discussions on concerns about global living standards and increasing health care costs. Whether chronic diseases, cognitive deficits or cardiovascular and metabolic disorders, this conference will allow us to deepen the interaction between specific trajectories and therapeutic interventions designed to address them, both in terms of preventive measures and treatment.« , concluded Ms. Alon.
The conference will cover the whole life sciences industry, including biopharmacy, medical devices, digital health and diagnostic products and technologies.
